IRADIMED CORPORATION to Hold 2019 Fourth Quarter Financial Results Conference Call on February 6th
22 janv. 2020 07h00 HE
|
iRadimed Corporation
WINTER SPRINGS, Fla., Jan. 22, 2020 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (NASDAQ: IRMD) announced today that the Company will release its 2019 fourth quarter financial results before the...
IRADIMED CORPORATION Announces Retirement of Brent Johnson and the Appointment of MaryBeth Smith as Vice President of Worldwide Sales
07 janv. 2020 07h00 HE
|
iRadimed Corporation
WINTER SPRINGS, Fla., Jan. 07, 2020 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (NASDAQ: IRMD) announced the retirement of Brent Johnson, Executive Vice President of Worldwide Sales and Marketing,...
IRADIMED CORPORATION Completes CE Mark Renewal Process For Its MRI Compatible Patient Vital Signs Monitoring System
12 déc. 2019 08h55 HE
|
iRadimed Corporation
Immediately resumes shipments of patient vital signs monitoring systems into all markets requiring CE Mark WINTER SPRINGS, Fla., Dec. 12, 2019 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (NASDAQ:...
IRADIMED CORPORATION Announces Third Quarter 2019 Financial Results
30 oct. 2019 07h00 HE
|
iRadimed Corporation
Reports third quarter 2019 revenue of $10.0 million, GAAP diluted EPS of $0.20 and non-GAAP diluted EPS of $0.23Updates full-year financial guidance WINTER SPRINGS, Fla., Oct. 30, 2019 (GLOBE...
IRADIMED CORPORATION to Hold 2019 Third Quarter Financial Results Conference Call on October 30th
16 oct. 2019 07h00 HE
|
iRadimed Corporation
WINTER SPRINGS, Fla., Oct. 16, 2019 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (NASDAQ: IRMD) announced today that the Company will release its 2019 third quarter financial results before the market...
IRADIMED CORPORATION Resolves Warning Letter Related to Its Infusion Pump System
08 oct. 2019 07h00 HE
|
iRadimed Corporation
WINTER SPRINGS, Fla., Oct. 08, 2019 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (NASDAQ: IRMD), today announced that it received a close-out letter from the U.S. Food and Drug Administration resolving...
IRADIMED CORPORATION to Participate in the Morgan Stanley 17th Annual Global Healthcare Conference
27 août 2019 16h15 HE
|
iRadimed Corporation
WINTER SPRINGS, Fla., Aug. 27, 2019 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (NASDAQ: IRMD), today announced that Leslie McDonnell, President and Chief Executive Officer, Roger Susi, Chairman and...
IRADIMED CORPORATION Announces Second Quarter 2019 Financial Results
30 juil. 2019 07h00 HE
|
iRadimed Corporation
Reports second quarter 2019 revenue of $9.2 millionReports second quarter 2019 GAAP diluted EPS of $0.17 and non-GAAP diluted EPS of $0.20Updates full year earnings guidance WINTER SPRINGS, Fla.,...
IRADIMED CORPORATION Names Leslie McDonnell as President and Chief Executive Officer
29 juil. 2019 16h00 HE
|
iRadimed Corporation
WINTER SPRINGS, Fla., July 29, 2019 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (NASDAQ: IRMD) announced today that its Board of Directors unanimously appointed Leslie McDonnell, to succeed Roger Susi...
IRADIMED CORPORATION to Hold 2019 Second Quarter Financial Results Conference Call on July 30th
16 juil. 2019 07h00 HE
|
iRadimed Corporation
WINTER SPRINGS, Fla., July 16, 2019 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (NASDAQ: IRMD) announced today that the Company will release its 2019 second quarter financial results before the market...